Blueprint Medicines shares owned by T. Rowe Price Investment Management
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by T. Rowe Price Investment Management
from 13F filings
Historical chart of T. Rowe Price Investment Management investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by T. Rowe Price Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $61M | 697k | 87.22 |
| 2024-09-30 | $69M | 749k | 92.50 |
| 2024-06-30 | $85M | 792k | 107.78 |
| 2024-03-31 | $95M | 1.0M | 94.86 |
| 2023-09-30 | $123M | 2.5M | 50.22 |
| 2023-06-30 | $155M | 2.5M | 63.20 |
| 2023-03-31 | $112M | 2.5M | 44.99 |
| 2022-12-31 | $109M | 2.5M | 43.81 |
More positions owned by T. Rowe Price Investment Management
View all positions for T. Rowe Price Investment Management